Tusc3-flox Mouse
Common Name
Tusc3-flox
제품 ID
S-CKO-16932
Backgroud
C57BL/6NCya
품종 계통계통 ID
CKOCMP-80286-Tusc3-B6N-VA
상태
이 마우스 계통을 논문에서 사용할 경우, “Tusc3-flox Mouse (카탈로그 번호 S-CKO-16932)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
기본 정보
품종 계통
Tusc3-flox
품종 계통계통 ID
CKOCMP-80286-Tusc3-B6N-VA
유전자명
제품 ID
S-CKO-16932
유전자 별칭
N33
배경
C57BL/6NCya
NCBI ID
변형 내용
Conditional knockout
염색체
Chr 8
Phenotype
Datasheet
적용 분야
--
품종 계통 설명
Ensembl 전사체 ID
ENSMUST00000239508
NCBI 전사체 ID
NM_030254
타겟 영역
Exon 2
유효 영역 크기
~0.6 kb
유전자 연구 개요
TUSC3, short for Tumor Suppressor Candidate 3, is a gene located on chromosome 8p22. It encodes a 34 kD protein which is a subunit of the oligosaccharyl transferase responsible for the N-glycosylation of nascent proteins in the endoplasmic reticulum [1]. It is also involved in magnesium transport and homeostasis as an Mg2+-transporter, which is crucial for learning and memory, embryonic development, and testis maturation [1]. Dysregulation of TUSC3 has been linked to various diseases, especially cancer, highlighting its biological importance. Genetic models, such as gene knockout models, can be valuable for studying its functions.
In cervical squamous cell carcinoma, down-regulation of TUSC3 promoted cell metastasis via the AKT signalling pathway, suggesting it may serve as a prognostic marker and potential target [2]. In hepatocellular carcinoma, decreased TUSC3 expression led to enhanced cell proliferation and migration, and it regulated epithelial-mesenchymal transition (EMT) through the LIPC/AKT axis [3]. In colorectal cancer, TUSC3 was found to promote the formation of cellular stemness and induce drug resistance via the Hedgehog signalling pathway [4]. Also, its promoter methylation in peripheral blood cells shows promise as a biomarker for CRC diagnosis [5]. In clear cell renal cell carcinoma, TUSC3 expression was downregulated, and it may inhibit the progression of the disease, potentially serving as a tumor marker for early diagnosis and prognosis [6]. In glioblastoma, epigenetic reactivation of TUSC3 can reprogram sensitivity to temozolomide regardless of MGMT promoter methylation status [7].
In conclusion, TUSC3 is essential for protein N-glycosylation and magnesium homeostasis. Through gene knockout or other loss-of-function models in various cancers, it has been revealed that TUSC3 plays significant roles in cancer cell proliferation, invasion, metastasis, drug resistance, and EMT. Understanding TUSC3 functions can provide new insights into cancer mechanisms and potential therapeutic targets. Additionally, its potential as a biomarker in cancer diagnosis and as a therapeutic target in XMEN disease further emphasizes its importance in biomedical research.
References:
1. Yu, Xinshuang, Zhai, Chunjuan, Fan, Yujun, Wang, Jia, Du, Juan. 2017. TUSC3: a novel tumour suppressor gene and its functional implications. In Journal of cellular and molecular medicine, 21, 1711-1718. doi:10.1111/jcmm.13128. https://pubmed.ncbi.nlm.nih.gov/28272772/
2. Sun, Fei, Jie, Qiuling, Li, Qi, Yue, Xiaojing, Ma, Yanlin. 2022. TUSC3 inhibits cell proliferation and invasion in cervical squamous cell carcinoma via suppression of the AKT signalling pathway. In Journal of cellular and molecular medicine, 26, 1629-1642. doi:10.1111/jcmm.17204. https://pubmed.ncbi.nlm.nih.gov/35137520/
3. Deng, Ruxia, Lu, Xiansheng, Hong, Chang, Chen, Qiaoyu, Lin, Jie. 2022. Downregulation of TUSC3 promotes EMT and hepatocellular carcinoma progression through LIPC/AKT axis. In Journal of translational medicine, 20, 485. doi:10.1186/s12967-022-03690-3. https://pubmed.ncbi.nlm.nih.gov/36274132/
4. Ren, Yansong, Deng, Ruxia, Cai, Rui, Ding, Yanqing, Lin, Jie. . TUSC3 induces drug resistance and cellular stemness via Hedgehog signaling pathway in colorectal cancer. In Carcinogenesis, 41, 1755-1766. doi:10.1093/carcin/bgaa038. https://pubmed.ncbi.nlm.nih.gov/32338281/
5. Siri, Goli, Mosallaei, Meysam, Ehtesham, Naeim, Nasrollahzadeh Sabet, Mehrdad, Behroozi, Javad. 2023. TUSC3 Methylation in Peripheral Blood Cells as a Biomarker for Diagnosis of Colorectal Cancer. In Advanced biomedical research, 12, 174. doi:10.4103/abr.abr_396_22. https://pubmed.ncbi.nlm.nih.gov/37564442/
6. Yan, Youji, Chen, Zhongjun, Liao, Yixiang, Zhou, Jiajie. 2019. TUSC3 as a potential biomarker for prognosis in clear cell renal cell carcinoma. In Oncology letters, 17, 5073-5079. doi:10.3892/ol.2019.10161. https://pubmed.ncbi.nlm.nih.gov/31186719/
7. Wu, Qiong, Berglund, Anders E, Macaulay, Robert J, Etame, Arnold B. 2023. Epigenetic Activation of TUSC3 Sensitizes Glioblastoma to Temozolomide Independent of MGMT Promoter Methylation Status. In International journal of molecular sciences, 24, . doi:10.3390/ijms242015179. https://pubmed.ncbi.nlm.nih.gov/37894860/
품질 관리 기준
정자 검사
동결 보존 전: 정자 농도 측정 및 정자 생존율 평가.
동결 보존 후: 각 배치에서 동결 보존된 정자 바이알 1개를 선택하여 체외수정(in vitro fertilization)에 사용합니다.
Environmental Standards:
SPFAvailable Region:
GlobalSource:
Cyagen문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
